1. A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open‐label extension. Issue 9 (26th October 2022) Authors: Yonker, Marcy E.; McVige, Jennifer; Zeitlin, Leonid; Visser, Hester Journal: Headache Issue: Volume 62:Issue 9(2022) Page Start: 1207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Practical Concussion Physical Examination Toolbox: Evidence-Based Physical Examination for Concussion. (May 2016) Authors: Matuszak, Jason M.; McVige, Jennifer; McPherson, Jacob; Willer, Barry; Leddy, John Journal: Sports health Issue: Volume 8:Number 3(2016:May/Jun.) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Treatment of Patients With Concussion. (4th January 2022) Authors: McVige, Jennifer; Rooney, Megan; Lis, Dylan Journal: Neurology Issue: Volume 98:Number 1(2022)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Coding in Behavioral Neurology and Neuropsychiatry. Issue 3 (June 2015) Authors: Fritz, Joseph V.; McVige, Jennifer; Mechtler, Laszlo Journal: Continuum Issue: Volume 21:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of Remote Electrical Neuromodulation and Standard-Care Medications for Acute Treatment of Migraine in Adolescents: A Post Hoc Analysis. Issue 4 (29th June 2021) Authors: Hershey, Andrew D; Irwin, Samantha; Rabany, Liron; Gruper, Yaron; Ironi, Alon; Harris, Dagan; Sharon, Roni; McVige, Jennifer Journal: Pain medicine Issue: Volume 23:Issue 4(2022) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Post-traumatic headache: Pathophysiology and management - A review. (May 2022) Authors: Blumenfeld, Andrew; McVige, Jennifer; Knievel, Kerry Journal: Journal of concussion Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine. (July 2022) Authors: Mechtler, Laszlo; Saikali, Nicolas; McVige, Jennifer; Hughes, Olivia; Traut, Alexandra; Adams, Aubrey Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-World Persistence and Costs Among Patients With Chronic Migraine Treated With OnabotulinumtoxinA or Calcitonin Gene–Related Peptide Monoclonal Antibodies: A Retrospective Claims Analysis Study. (July 2022) Authors: Schwedt, Todd J.; Lee, Jae; Knievel, Kerry; McVige, Jennifer; Wang, Weiying; Wu, Zheng; Gillard, Patrick; Shah, Darshini; Blumenfeld, Andrew M. Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial. (January 2023) Authors: Klein, Brad C; Miceli, Rosa; Severt, Lawrence; McAllister, Peter; Mechtler, Laszlo; McVige, Jennifer; Diamond, Merle; Marmura, Michael J; Guo, Hua; Finnegan, Michelle; Trugman, Joel M Journal: Cephalalgia Issue: Volume 43:Number 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗